Zilovertamab vedotin
Zilovertamab vedotin (VLS-101, MK-2140) is an antibody-drug conjugate (ADC) composed of a humanised monoclonal antibody targeting ROR1 and the anti-mitotic cytotoxic agent monomethyl auristatin E (MMAE). It has potential for the treatment of lymphoid malignancies.
Supplier | Selleck Chemicals |
---|---|
Product # | D4013 |
Sku # | D4013-1mg |
Pricing | 1mg, $970.00 |